TCRX Competitors & Alternatives
Compare Tscan Therapeutics Inc with similar stocks in the same industry
Biotechnology
TCRX
Main Stock$1.26
Tradestie Score
54
Market Cap
$118.60M
Revenue Growth
2.9%
Analyst Upside
+376.2%
Top Competitors
228 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
FBRX
Forte Biosciences, Inc. Common Stock
|
$24.02
|
$180.53M | - | 45 | Compare |
|
AVTX
Avalo Therapeutics, Inc. Common Stock
|
$21.57
|
$170.45M | - | 57 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$11.37
|
$133.50M | - | 56 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$24.26
|
$110.20M | - | 52 | Compare |
|
ABOS
Acumen Pharmaceuticals, Inc. Common Stock
|
$2.56
|
$106.00M | - | 57 | Compare |
|
HOWL
Werewolf Therapeutics, Inc. Common Stock
|
$0.68
|
$89.17M | - | 50 | Compare |
|
STRO
Sutro Biopharma, Inc.
|
$40.24
|
$76.55M | - | 63 | Compare |
|
RLMD
Relmada Therapeutics, Inc. Common Stock
|
$7.32
|
$71.69M | - | 60 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$9.75
|
$67.94M | - | 55 | Compare |
|
INAB
IN8bio, Inc. Common Stock
|
$1.58
|
$10.26M | - | 62 | Compare |
More TCRX Analysis
Data updated: May 08, 2026 | Industry: Biotechnology (SIC 2836)
228 stocks in this industry